2WS-13576-95790
3 vaccinations
2 coded responses
32 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 150 / PA
- Registered
- 2021-07-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-15
Registered in v-safe
-
2021-07-15
Dose 1 — Pfizer-BioNTech
- 2021-07-15
-
2021-07-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-07-17
- 2021-07-18
-
2021-07-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-07-20
- 2021-07-21
- 2021-07-22
- 2021-07-29
-
2021-08-05
Dose 2 — Pfizer-BioNTech
- 2021-08-12
- 2021-08-19
- 2021-08-26
- 2021-09-02
- 2021-09-09
- 2021-09-16
-
2021-11-04
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sore throat and coldMedDRA releases: 2024-11 · check-in free text available
-
2021-11-04
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-05
-
2022-02-05
Dose 3 — Pfizer-BioNTech
- 2022-02-05
-
2022-02-05
Survey response — 6 months, dose 2MedDRA: Vomiting — Feeling: Good · Be unable to do your normal daily activitiesFree text: VomitingMedDRA releases: 2024-11 · check-in free text available
- 2022-02-06
- 2022-02-08
-
2022-02-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Muscle or body achesAdult check-in
- 2022-02-10
- 2022-02-11
- 2022-02-12
- 2022-02-19
- 2022-02-27
- 2022-03-05
- 2022-03-12
- 2022-03-19
- 2022-05-07
- 2022-08-06
- 2023-02-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-15 | Pfizer-BioNTech | No |
| 2 | 2021-08-05 | Pfizer-BioNTech | No |
| 3 | 2022-02-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-04 | Unsuccessful |
Free text
Release 10 — 3 months, dose 2
Symptoms: Sore throat and cold
Release 11 — 6 months, dose 2
Symptoms: Vomiting
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release